Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma

BACKGROUND: Refractory or relapsed Hodgkin's disease (HD) occurs in 10-50% of patients. The treatment of choice for these patients is high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT). Response to salvage chemotherapy (SCT) partial remission (PR) is necessary before...

詳細記述

保存先:
書誌詳細
出版年:Adv Biomed Res
主要な著者: Mehrzad, Valiollah, Ashrafi, Farzaneh, Farrashi, Ali Reza, Pourmarjani, Reyhaneh, Dehghani, Mehdi, Shahsanaei, Armindokht
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2017
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5360016/
https://ncbi.nlm.nih.gov/pubmed/28401077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2277-9175.201687
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料